Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)[2] Daratumumab,
Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)		[1] D10777 [1] CD38 💬[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[1] 28
2PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20[1] Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)---[1] 28
3Recombinant human hyaluronidase[1] Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)---[3] 14, 28, 65
4Recombinant Human Hyaluronidase (rHuPH20)[1] Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)---[1] 65
5Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)[1] Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)---[1] 65
6Recombinant human hyaluronidase + immune globulin intravenous[2] Hyaluronidase,
Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)		[3] D04455 ,
D04456 ,
D06604 		--[1] 65
7Recombinant human hyaluronidase PH20[2] Hyaluronidase,
Hyaluronidase (human recombinant) (Synonym: Recombinant human hyaluronidase)		[3] D04455 ,
D04456 ,
D06604 		--[1] 28